Blue Pool Capital is a Hong Kong-based investment advisory firm established in 2003 and licensed by the Hong Kong Securities and Futures Commission. The firm specializes in global macro and emerging market investment strategies, leveraging the extensive experience of its team, which has previously collaborated at Investor AB. With a profound understanding of Asian markets, Blue Pool Capital has successfully navigated various investment cycles in the region. The team’s diverse operational backgrounds across multiple industries enhance their insight into the challenges and opportunities faced by investee companies, providing them with valuable information that precedes broader market trends.
Founder and Managing Partner, Chief Investment Officer
Christopher Wu
Partner
22 past transactions
Tabby
Series E in 2025
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
Golden Goose
Venture Round in 2025
Golden Goose is a notable luxury fashion brand recognized for its distinctive sneakers. The company operates within the fashion industry, focusing on the production and sale of a range of products, including clothing, accessories, and bags. Known for its unique designs, Golden Goose has carved out a niche in the competitive luxury market, appealing to consumers who value both style and quality.
Cambium Carbon
Seed Round in 2023
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.
Tabby
Series D in 2023
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
GetYourGuide
Series F in 2023
GetYourGuide is an online platform that facilitates the booking of tours, attractions, and activities around the globe. Founded in 2009 by Jochen Mattes, Johannes Reck, Martin Sieber, Pascal Mathis, Tao Tao, and Tobias Rein, the platform provides a wide range of services, including tickets to tourist attractions, cooking classes, and various experiential activities. By acting as an intermediary, GetYourGuide allows customers to book these experiences at no direct cost to them; instead, tour providers pay a percentage of their revenue to the platform. This model not only streamlines the booking process for travelers but also includes a customer review system that helps users assess the quality of tour providers. To maintain high standards, GetYourGuide removes consistently poorly reviewed providers from its offerings, ensuring a reliable selection of experiences for users.
Artifact Labs
Seed Round in 2023
Artifact Labs is a pioneering company specializing in Web3 and non-fungible token (NFT) technology. It develops and operates a multi-chain NFT ecosystem, enabling organizations to transform physical assets into digital collections on the blockchain. By preserving historical records and raising awareness of cultural heritage, Artifact Labs helps organizations tap into new revenue streams to support their preservation efforts.
Premier Lacrosse League
Series D in 2022
Premier Lacrosse League is a professional lacrosse organization in North America that aims to elevate the sport through a tour-based model. It features a roster of top players, showcasing the biggest stars in lacrosse and providing fans with an engaging entertainment experience. By operating a series of tournaments, the league seeks to bring lacrosse to a national audience, promoting its growth and popularity. In addition to its events, Premier Lacrosse League also sells sports-related apparel online, further connecting with its fanbase and enhancing the overall lacrosse experience.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.
Aver
Seed Round in 2022
Aver is a decentralized peer-to-peer betting exchange built on the Solana blockchain and the world’s first decentralized Web3 betting exchange.
Artemis
Pre Seed Round in 2021
Artemis is a decentralized mobile-focused NFT social and trading platform.
Animoca Brands
Venture Round in 2021
Animoca Brands, established in 2019 and headquartered in the Cayman Islands, is a venture capital firm focused on the technology sector. It invests in and supports creators who leverage web3 and blockchain technologies to drive digital property rights to gamers and internet users through non-fungible tokens (NFTs). The company develops and markets a portfolio of mobile applications, games, and educational products, utilizing gamification and blockchain to ensure transparency, security, and innovative business models.
LifeMine Therapeutics
Series B in 2021
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.
FogPharma
Venture Round in 2021
FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.
PlayVS
Series C in 2020
PlayVS is an operator of an eSports platform designed to facilitate organized competitions for high schools. The company provides a platform that enables the organization of online tournaments, allowing students to compete against one another for cash prizes and titles. By fostering eSports programs in high schools, PlayVS helps teen gamers form teams and engage in competitive play, connecting them with players from other schools and creating opportunities to participate in state championships. This initiative aims to enhance the overall experience of high school eSports, ensuring that both players and schools can stay informed and involved in the rapidly evolving world of competitive gaming.
Brii Biosciences
Venture Round in 2018
Brii Biosciences Limited is a biotechnology company focused on the research, development, and commercialization of innovative medicines for chronic and infectious diseases, including hepatitis B virus (HBV), human immunodeficiency virus (HIV), and multi-drug resistant infections. Founded in 2018, the company is headquartered in Durham, North Carolina, with additional offices in Shanghai, Beijing, and San Francisco. Brii Biosciences aims to enhance healthcare outcomes for patients in China by leveraging advanced technology and data. The company has established strategic partnerships with organizations such as AliHealth and Vir to further its mission. With a robust pipeline consisting of over 10 product candidates, Brii Biosciences is dedicated to addressing significant public health challenges both in China and globally, focusing on delivering better treatments and cures for life-threatening diseases.
GRAIL
Series C in 2018
GRAIL, Inc. is a healthcare company dedicated to advancing technologies for early cancer detection. Founded in 2015 and headquartered in Menlo Park, California, GRAIL has developed Galleri, a screening test aimed at asymptomatic individuals over 50 years old, and DAC, a diagnostic aid designed to expedite the resolution of cancer diagnoses in patients with clinical suspicions. The company also focuses on creating minimal residual disease tests and other post-diagnostic solutions. GRAIL's innovative approach includes a pan-cancer screening test that utilizes high-intensity sequencing to analyze circulating nucleic acids in blood, enabling the potential to detect various types of cancer at early stages.
FogPharma
Series B in 2018
FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.
Hua Medicine
Series D in 2018
Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.
Rent The Runway
Venture Round in 2018
Rent the Runway, Inc. is an e-commerce platform that allows women to rent designer apparel and accessories, offering a transformative approach to fashion consumption. Founded in 2008 and based in New York, the company provides a range of options including party dresses, gowns, jumpsuits, outerwear, and accessories such as jewelry and handbags. Rent the Runway operates both an online platform and physical stores in locations like New York City, San Francisco, Santa Monica, and Washington, D.C. Through its subscription model, users can access an extensive collection of clothing for various occasions, while also having the option to rent items a-la-carte or purchase them outright. The company emphasizes sustainability and empowerment, catering to modern women's needs in a rapidly evolving fashion landscape.
LifeMine Therapeutics
Series A in 2017
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.
Lytro
Series D in 2017
Lytro is a pioneering company focused on developing advanced Light Field imaging platform technologies, enabling artists, scientists, and innovators to achieve unprecedented creative freedom and control. Founded in 2006 by Ren Ng, who earned recognition for his groundbreaking Ph.D. research in Light Field imaging, Lytro introduced its first consumer Light Field camera in 2012. This was followed by the release of the Lytro ILLUM and associated software tools in 2014, which expanded the application of Light Field technology beyond photography to various fields, including cinematography and industrial uses. In 2015, Lytro further diversified its offerings by entering the realms of virtual reality and scientific applications, establishing itself as a central player in a new technology ecosystem. With a commitment to enhancing visual quality and creative possibilities, Lytro’s products allow users to capture multi-dimensional data from multiple angles, thereby transforming the landscape of computational imaging. The company is headquartered in Mountain View, California.
Fanatics
Fanatics, Inc. is a leading global e-commerce company specializing in licensed sports merchandise, including fan gear and jerseys. Founded in 1995 and headquartered in Jacksonville, Florida, the company operates a multi-channel retail platform that serves professional sports leagues, media brands, and collegiate teams. Fanatics designs, manufactures, and distributes its products across various channels, including online, mobile, and physical stores, catering to the evolving needs of sports fans in a mobile-first, on-demand culture. The company has additional offices in San Mateo, California, and Manchester, United Kingdom, and aims to enhance the shopping experience by providing a wide range of products that meet the real-time expectations of customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.